Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Novel Mechanism
100%
Brain Metastatic Breast Cancer
100%
Lapatinib
100%
Heparanase
100%
Roneparstat
66%
Resistant Clones
33%
Human Epidermal Growth Factor Receptor 2 (HER2)
22%
Lapatinib Resistance
22%
Molecular Mechanism
11%
Mechanistic Insight
11%
High Risk
11%
Breast Cancer Treatment
11%
Therapeutic Potential
11%
Response Rate
11%
Cell Growth
11%
U.S. Food
11%
Small Molecule Inhibitors
11%
Angiogenic
11%
Risk Prediction
11%
Breast Cancer Recurrence
11%
Tyrosine Residue
11%
Survival Pathways
11%
Intracranial Metastases
11%
Cancer Onset
11%
Endoglycosidase
11%
EGFR Phosphorylation
11%
EGFR Signaling Pathway
11%
Pro-metastatic
11%
Human Epidermal Growth Factor
11%
Dual Inhibitor
11%
Cancer Therapeutic Strategy
11%
EGFR Pathway
11%
Non-anticoagulant Heparin
11%
Tykerb
11%
Pharmacology, Toxicology and Pharmaceutical Science
Metastatic Breast Cancer
100%
Lapatinib
100%
Heparanase
100%
Epidermal Growth Factor Receptor
54%
Roneparstat
54%
Breast Cancer
9%
Anticoagulant Agent
9%
Heparin
9%
Gamma Urogastrone
9%